Magrath George 4

What Happened
George Magrath, Chief Executive Officer of Opus Genetics, sold 9,475 shares on July 23, 2026 in an open-market/private sale. The weighted-average sale price was $2.95 per share (range $2.9009–$3.025), for proceeds of approximately $27,926. This disposition was executed to satisfy tax withholding obligations tied to a restricted stock unit (RSU) vesting event and was not a discretionary trade by the CEO.

Key Details

• Transaction type: Sale (reported as S); transaction date: 2026-07-23; filing date: 2026-07-27.
• Price: Weighted average $2.95; individual trade prices ranged from $2.9009 to $3.025. The filer offered to provide a price-by-price breakdown on request (Footnote F2).
• Reason/footnote: Sold automatically to satisfy tax withholding from an RSU vesting/settlement (Footnote F1). Not a voluntary market-timing sale.
• Shares owned after transaction: Not specified in the provided filing.
• Timeliness: Filed 2026-07-27; based on the reported dates this appears to meet the Form 4 two-business-day filing requirement.

Context
This was a tax-withholding sale tied to equity compensation (RSUs), a common administrative transaction that does not necessarily reflect the insider’s view on the company’s stock. Purchases are typically more informative about insider confidence; this sale appears routine.